ARCHIVES

Interview With Departing NCI Director; Advice To His Successor.

This article is from The Cancer Letter archive.

Vol. 36 No. 26 | July 9, 2010

Download PDF Visit The Full Archive

Related Articles

Group trials need prioritization, review, NCI official says.

July 25, 2003

Program Project Scores Have Compressed Review Shuld Return To Rank Order; Broder

October 2, 1992

Telatinib Demonstrates Positive Results in First-Line Treatment

June 24, 2011

Angiogenesis Inhibitor In Phase III Trials For Metastatic Colorectal Cancer

September 26, 2003

As Zeneca Buys Salick, Implications For Oncology Managed Care Uncertain

April 4, 1997

Recommendations For Adjuvant Therapy In Breast Cancer

September 20, 1985